These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 19528564)
1. Narrative review: statin-related myopathy. Joy TR; Hegele RA Ann Intern Med; 2009 Jun; 150(12):858-68. PubMed ID: 19528564 [TBL] [Abstract][Full Text] [Related]
2. Statin-induced myopathy: a review and update. Abd TT; Jacobson TA Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078 [TBL] [Abstract][Full Text] [Related]
3. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Harper CR; Jacobson TA Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856 [TBL] [Abstract][Full Text] [Related]
4. Intermittent nondaily dosing strategies in patients with previous statin-induced myopathy. Keating AJ; Campbell KB; Guyton JR Ann Pharmacother; 2013 Mar; 47(3):398-404. PubMed ID: 23482733 [TBL] [Abstract][Full Text] [Related]
5. Managing the underestimated risk of statin-associated myopathy. Rallidis LS; Fountoulaki K; Anastasiou-Nana M Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193 [TBL] [Abstract][Full Text] [Related]
6. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators. Whayne TF Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631 [TBL] [Abstract][Full Text] [Related]
9. Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999 [TBL] [Abstract][Full Text] [Related]
10. The role of mitochondria in statin-induced myopathy. Apostolopoulou M; Corsini A; Roden M Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405 [TBL] [Abstract][Full Text] [Related]
11. Statin myotoxicity: a review of genetic susceptibility factors. Needham M; Mastaglia FL Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465 [TBL] [Abstract][Full Text] [Related]
13. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283 [TBL] [Abstract][Full Text] [Related]
14. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
15. Clinical characterization and molecular mechanisms of statin myopathy. Toth PP; Harper CR; Jacobson TA Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):955-69. PubMed ID: 18666846 [TBL] [Abstract][Full Text] [Related]
16. Statin intolerance. Ahmad Z Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743 [TBL] [Abstract][Full Text] [Related]
17. Statins' effect on plasma levels of Coenzyme Q10 and improvement in myopathy with supplementation. Littlefield N; Beckstrand RL; Luthy KE J Am Assoc Nurse Pract; 2014 Feb; 26(2):85-90. PubMed ID: 24170646 [TBL] [Abstract][Full Text] [Related]
18. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects. Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054 [TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q(10) and statin myalgia: what is the evidence? Mas E; Mori TA Curr Atheroscler Rep; 2010 Nov; 12(6):407-13. PubMed ID: 20725809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]